Why A Vaccine Won’t Be a Quick Fix for COVID-19
Tedros Adhanom Ghebreyesus, director-common, Environment Wellbeing Group, Geneva, Switzerland.
Barry Bloom, PhD, Joan L. and Julius H. Jacobson investigation professor of public health, T.H. Chan Faculty of Community Wellbeing, Harvard College, Cambridge, MA.
Robert Litan, PhD, JD, nonresident senior fellow, financial research, the Brookings Institute, Washington, D.C.
Gregory Poland, MD, professor of medicine, internist, Mayo Clinic, Rochester, MN.
Nationwide Academies Press: “Discussion Draft of the Preliminary Framework for Equitable Allocation of a COVID-19 Vaccine,” Sept. 1, 2020.
Environment Wellbeing Group: “Draft Landscape of COVID-19 Applicant Vaccines,” accessed Sept. 1, 2020.
U.S. Department of Wellbeing and Human Solutions: “Explaining Procedure Warp Pace,” accessed, Sept. 1, 2020.
U.S. Govt Accountability Business office: “Herd Immunity for COVID-19,” July seven, 2020.
Gallup Poll: “One in 3 Americans Would not get COVID-19 Vaccine,” Aug. seven, 2020.
Information Release, Food and drug administration, June thirty, 2020.
The Lancet: “COVID-19 vaccine trials really should seek worthwhile efficacy.”